 |
|
Scientists one step closer to cancer vaccine
March 22, 2006Scientists at Karolinska Institutet in Sweden have helped to identify a molecule that can be used as a vaccination agent against growing cancer tumours. Although the results are so far based on animal experiments, they point to new methods of treating metastases.
The results are presented in the online edition of the prestigious scientific journal Nature Medicine, and represent the collaborative efforts of researchers at KI and Leiden University Medical Centre in Holland.
The study analysed an immunological cell, a T cell, which recognises other cells with defects common to metastasing ones. These defects (which are found in MHC class 1 molecules) allow the tumour cell to evade the "conventional" T cell-mediated immune defence.
The researchers have identified a short peptide molecule that the T cell in the study recognises. Using this peptide, the researchers can vaccinate and protect against the spread of tumours from different tissues, including melanoma, colon cancer, lymphoma, and fibrosarcoma.
"So far we've only conducted research on mice, so it's too early to get out hopes up too much," says research scientist Elisabeth Wolpert at the Microbiology and Tumour Biology Centre. "However, the study does point towards new possible ways of developing a treatment for advanced tumour diseases."
The newly published study is a continuation of an original discovery that first identified the TEIPP-T cell and that was presented in Ms Wolpert's doctoral thesis at Karolinska Institutet in 1998.
The spread of tumours, or metastases, is the most common cause of death from cancer.
Karolinska Institutet
The researchers have identified a short peptide molecule that the T cell in the study recognises. Using this peptide, the researchers can vaccinate and protect against the spread of tumours from different tissues, including melanoma, colon cancer, lymphoma, and fibrosarcoma.
"So far we've only conducted research on mice, so it's too early to get out hopes up too much," says research scientist Elisabeth Wolpert at the Microbiology and Tumour Biology Centre. "However, the study does point towards new possible ways of developing a treatment for advanced tumour diseases."
The newly published study is a continuation of an original discovery that first identified the TEIPP-T cell and that was presented in Ms Wolpert's doctoral thesis at Karolinska Institutet in 1998.
The spread of tumours, or metastases, is the most common cause of death from cancer.
Karolinska Institutet
Cancer Vaccine News and Current Cancer Vaccine Events RSSDifferent type of colon cancer vaccine reduces disease spread, Jefferson scientists show
Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease.
Math could help cure leukemia
When kids complain that math homework won't help them in real life, a new answer might be that math could help cure cancer.
Vaccine/antibody therapy effective, milder side effects in melanoma and ovarian cancer
One of the shortcomings of a therapy that uses millions of identical antibodies to boost the immune system's attack on cancer cells is that many patients whose tumors recede in response to the treatment also experience serious inflammatory problems, such as severe diarrhea and rashes.
Resisting lung cancer recurrence
What if we could prevent cancer recurrence for years after surgery by giving simple recall injections every two or three years" This concept may no longer be a fantasy.
Prostate cancer: Watchful wait or vaccinate?
Researchers at the University of Southern California have developed a prostate cancer vaccine that prevented the development of cancer in 90 percent of young mice genetically predestined to develop the disease.
Researchers train the immune system to deliver virus that destroys cancer in lab models
An international team of researchers led by Mayo Clinic have designed a technique that uses the body's own cells and a virus to destroy cancer cells that spread from primary tumors to other parts of the body through the lymphatic system.
UGA researchers one step closer to cancer vaccine
When cells become cancerous, the sugars on their surfaces undergo distinct changes that set them apart from healthy cells. For decades, scientists have tried to exploit these differences by training the immune system to attack cancerous cells before they can spread and ravage the body.
Clinical trial evaluating brain cancer vaccine is underway at NYU
A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center.
Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd.
Warts vaccine -- 1 of many in pipeline
A clinical trial treating the papillomaviruses responsible for genital warts was on target at the halfway mark, according to Australian of the Year 2006 Professor Ian Frazer and trial manager, sexual health specialist Dr David Jardine.
More Cancer Vaccine News Articles
 | The Virus and the Vaccine: Contaminated Vaccine, Deadly Cancers, and Government Neglect by Debbie Bookchin, Jim Schumacher Past tragedies caused by "miracle drugs" have taught the public to approach cures with caution, and vaccines, in particular, have come under public scrutiny. In The Virus and the Vaccine, journalists Debbie Bookchin and Jim Schumacher uncover the true tale of the polio vaccine and its past and present dangers. Like many medical detective stories before it, this book starts with a chilling... |
| Conquest of Cancer: Vaccines and Diet by Virginia Livingston-Wheeler, Edmond G. Addeo | |
 | The HPV Vaccine Controversy: Sex, Cancer, God, and Politics: A Guide for Parents, Women, Men, and Teenagers by Shobha S. Krishnan The Human Papilloma Virus, so-called HPV, is one of the most widespread sexually transmitted diseases in America, with more than 20 million infected now and more than 6 million new cases detected each year. It is estimated that at least 50 percent of all sexually active people will be infected during their lifetimes. And while the "silent" disease may cause no symptoms in most cases, two strains... |
 | Targeted Therapies in Cancer (Recent Results in Cancer Research) From its introduction, oncological chemotherapy has been encumbered by its poor selectivity because most antiproliferative drugs are toxic not only to tumor cells but also to important populations of the body’s non-neoplastic cells. The resultant problems with unwanted side effects are compounded by difficulties in predicting the desired effectivity of chemotherapy in individual patients. ... |
 | Heat Shock Proteins in Cancer (Heat Shock Proteins) (Heat Shock Proteins) Heat shock proteins are emerging as important molecules in the development of cancer and as key targets in cancer therapy. These proteins enhance the growth of cancer cells and protect tumors from treatments such as drugs or surgery. However, new drugs have recently been developed particularly those targeting heat shock protein 90. As heat shock protein 90 functions to stabilize many of the... |
 | Cancer Vaccines and Tumor Immunity by Rimas Orentas, James W. Hodge, Bryon D., PhD Johnson Cancer Vaccines and Tumor Immunity offers a review of the basic scientific discoveries that have moved forward into clinical trials. Presented in the context of real-world human research and experimentation, these major scientific advances demonstrate how our understanding of immune activation, T-regulatory cells, and autoimmunity will impact cancer vaccine design. The authors also explain how... |
 | Cancer Vaccines: Challenges and Opportunities in Translation (Translational Medicine) Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist. Topics include: · personalized immunotherapies · the gap between preclinical models and clinical situation · biomarker guided R&D and clinical development · ... |
| Lovely Cancer Vaccine - The Hasumi Cancer Vaccine - The Future is Now | |
| THE CONQUEST OF CANCER - VACCINES AND DIET by LIVINGSTON-WHEELER DR. VIRGINIA | |
| The Conquest of Cancer: Vaccines and Diet by Dr Virginia Livingston Wheeler |
| © 2008 BrightSurf.com |